Get started
Author

Lene Hammer-Helmich

Observed names: Hammer-Helmich, Lene, L Hammer-Helmich, L. Hammer-Helmich, L. Hammer‐Helmich
Institution: Lundbeck (Denmark)
ORCID: 0000-0001-8962-6250
Observed ORCID: 0000-0001-8962-6250
OpenAlex ID: A5024700132
Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
2018 · Lene Hammer-Helmich, Josep Maria Haro, et al. · Neuropsychiatric Disease and Treatment · 150
PDF
Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
2018 · Delphine Saragoussi, Michael Cronquist Christensen, et al. · Neuropsychiatric Disease and Treatment · 120
PDF
Recent temporal trends in sleep duration, domain-specific sedentary behaviour and physical activity. A survey among 25–79-year-old Danish adults
2013 · Mette Aadahl, Anne Helms Andreasen, et al. · Scandinavian Journal of Public Health · 76
Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross–sectional analysis of baseline data from PERFORM-J
2019 · Tomiki Sumiyoshi, Koichiro Watanabe, et al. · Journal of Affective Disorders · 74
PDF
Association between parental socioeconomic position and prevalence of asthma, atopic eczema and hay fever in children
2013 · Lene Hammer-Helmich, Allan Linneberg, et al. · Scandinavian Journal of Public Health · 68
Agitation in patients with dementia: a systematic review of epidemiology and association with severity and course
2019 · Milena Anatchkova, Anne Brooks, et al. · International Psychogeriatrics · 58
PDF
Social disparities in children’s exposure to second hand smoke at home: a repeated cross-sectional survey
2012 · Charlotta Pisinger, Lene Hammer-Helmich, et al. · Environmental Health · 56
PDF
Mental health associations with eczema, asthma and hay fever in children: a cross-sectional survey
2016 · Lene Hammer-Helmich, Allan Linneberg, et al. · BMJ Open · 47
PDF
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
2022 · Gregory W. Mattingly, Hongye Ren, et al. · Frontiers in Psychiatry · 44
PDF
Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J
2021 · Tomiki Sumiyoshi, Koichiro Watanabe, et al. · Neuropsychiatric Disease and Treatment · 36
PDF
Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
2019 · Josep Maria Haro, Lene Hammer-Helmich, et al. · Neuropsychiatric Disease and Treatment · 26
PDF
Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
2022 · Gang Wang, Le Xiao, et al. · Neuropsychiatric Disease and Treatment · 23
PDF
Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study
2020 · Gang Wang, Kristin Hui Xian Tan, et al. · Neuropsychiatric Disease and Treatment · 18
PDF
Atopy and cause‐specific mortality
2014 · T. Skaaby, L. L. N. Husemoen, et al. · Clinical & Experimental Allergy · 17
Characterizing mood disorders in the AFFECT study: a large, longitudinal, and phenotypically rich genetic cohort in the US
2022 · Maria Dalby, Morana Vitezic, et al. · Translational Psychiatry · 16
PDF
Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study
2018 · Josep Maria Haro, François-Xavier Lamy, et al. · BMC Psychiatry · 12
PDF
Health service use among children with and without eczema, asthma, and hay fever
2016 · Allan Linneberg, Lene Hammer-Helmich, et al. · Clinical Epidemiology · 12
PDF
Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder
2021 · Tomiki Sumiyoshi, Tatsuya Hoshino, et al. · Journal of Affective Disorders · 10
PDF
Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS)
2023 · Agnete Skovlund Dissing, Xin Ying Lee, et al. · Neurology and Therapy · 8
PDF
Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy
2022 · Shinichi Noto, Mayumi Wake, et al. · Value in Health Regional Issues · 8
Sundhedsprofil for region og kommuner 2010
2010 · Hammer-Helmich, Lene, Buhelt, Lone Prip, et al. · Research at the University of Copenhagen (University of Copenhagen) · 8
A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting
2017 · Clément François, Alice Guiraud-Diawara, et al. · Journal of Market Access & Health Policy · 3
Molecular genetic influences on sustained attention and executive processes and their links with psychopathology in the AFFECT study
2026 · Justin D. Tubbs, Travis T. Mallard, et al. · Molecular Psychiatry · 2
PDF
Functional improvement as a treatment goal in major depressive disorder: a narrative review of the evidence for vortioxetine
2025 · Pratap Chokka, Lene Hammer-Helmich, et al. · Current Medical Research and Opinion · 2
P.0724 Vortioxetine in routine clinical practice: results from the real-life effectiveness of vortioxetine (RELIEVE) study
2021 · G. Mattingly, H. Ren, et al. · European Neuropsychopharmacology · 2
Works count: 43
Citation count: 903
H-index: 15
I10-index: 18
Year
Topic
Type